StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

DNTHBullishAnalyst Target Updateanalyst
Medium materiality6/10

Raymond James raises Dianthus Therapeutics target to $134

Nov 5, 2026, 7:25 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The target suggests substantial upside, though a single analyst forecast without stated rationale warrants limited confidence.

AI summary

What happened, with direct paths to the underlying reporting

Raymond James raised its DNTH price target to $134, about 56% above the posted price of $85.81. The record provides no supporting rationale.

  • Target: $134; posted price: $85.81.
  • Raymond James analyst: Ryan Deschner.

Key facts

  1. 01

    Target: $134

  2. 02

    Posted price: $85.81

  3. 03

    Analyst firm: Raymond James

  4. 04

    Analyst: Ryan Deschner

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.